Indica Labs announced that a global company has agreed to make a “significant strategic investment” in Indica.

The initiative will build and power the infrastructure required to digitize and deliver impactful AI-driven pathology solutions to patients and caregivers.

The organization is leveraging its growing bank of whole-slide pathology images to create models that could form the backbone of cancer testing applications.

JelloX Biotech Inc., a Taiwan-based startup focused on cancer pathology, is unveiling its vision for AI and 3D digital pathology to advance patient-centered care. The vision was first detailed ...

Against the backdrop of the 43rd Annual J.P. Morgan Healthcare Conference, Mayo Clinic announced the formation of Mayo Clinic Digital Pathology, designed on a platform architecture to boldly unlock ...

Building on 25 years of leading innovation, we are excited to unveil the latest groundbreaking advancements for our Aperio GT ...

Paige AI explains how its tools can facilitate quicker diagnostics and improve cost efficiency within the UK’s health system ...

Hyderabad: IIIT Hyderabad, in collaboration with Nizam's Institute of Medical Sciences (NIMS), has released digitised ...

Our Bureau, Bengaluru Friday, January 24, 2025, 14:30 Hrs [IST] ...

Aignostics announced research results for a new pathology foundation model developed in collaboration with Mayo Clinic ...

Enhancing clinical research in India with publicly accessible histopathological image datasets for cancer and kidney disease ...